Laddar...
Therapeutic strategies and mechanisms of tumorigenesis of HER2-overexpressing breast cancer
The receptor tyrosine kinase HER2 is overexpressed in approximately 25% of breast cancers. HER2 acts as a signal amplifier for its siblings, namely three different transmembrane receptors that collectively bind with 11 distinct growth factors of the EGF family. Thus, overexpression of HER2 confers a...
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2010
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3038194/ https://ncbi.nlm.nih.gov/pubmed/20951604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.critrevonc.2010.09.002 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|